These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23530915)

  • 21. The RRE-Rev Module Has No Effect on the Packaging Efficiency of Cas9 and Gag Proteins into NanoMEDIC Virus-like Particles.
    Kruglova NA; Komkov DS; Mazurov DV; Shepelev MV
    Dokl Biol Sci; 2023 Dec; 513(Suppl 1):S45-S50. PubMed ID: 38472686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and characterization of simian--human immunodeficiency virus-like particles.
    Yao Q; Kuhlmann FM; Eller R; Compans RW; Chen C
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):227-36. PubMed ID: 10710211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA packaging signal of human immunodeficiency virus type 1.
    Hayashi T; Shioda T; Iwakura Y; Shibuta H
    Virology; 1992 Jun; 188(2):590-9. PubMed ID: 1585635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles.
    Lu YL; Bennett RP; Wills JW; Gorelick R; Ratner L
    J Virol; 1995 Nov; 69(11):6873-9. PubMed ID: 7474102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA.
    Helga-Maria C; Hammarskjöld ML; Rekosh D
    J Virol; 1999 May; 73(5):4127-35. PubMed ID: 10196309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombination.
    Nikolaitchik O; Rhodes TD; Ott D; Hu WS
    J Virol; 2006 May; 80(10):4691-7. PubMed ID: 16641262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.
    Park J; Morrow CD
    J Virol; 1992 Nov; 66(11):6304-13. PubMed ID: 1383561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcellular Localization of HIV-1
    Becker JT; Sherer NM
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initiation site can restore viral replication.
    Liang C; Rong L; Laughrea M; Kleiman L; Wainberg MA
    J Virol; 1998 Aug; 72(8):6629-36. PubMed ID: 9658109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation.
    Schneider R; Campbell M; Nasioulas G; Felber BK; Pavlakis GN
    J Virol; 1997 Jul; 71(7):4892-903. PubMed ID: 9188551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
    Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC
    EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 Gag Forms Ribonucleoprotein Complexes with Unspliced Viral RNA at Transcription Sites.
    Tuffy KM; Maldonado RJK; Chang J; Rosenfeld P; Cochrane A; Parent LJ
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33182496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and Functional Characterization of a Biologically Active Full-Length Feline Immunodeficiency Virus (FIV) Pr50
    Krishnan A; Pillai VN; Chameettachal A; Mohamed Ali L; Nuzra Nagoor Pitchai F; Tariq S; Mustafa F; Marquet R; A Rizvi T
    Viruses; 2019 Jul; 11(8):. PubMed ID: 31357656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An RNA-binding compound that stabilizes the HIV-1 gRNA packaging signal structure and specifically blocks HIV-1 RNA encapsidation.
    Ingemarsdotter CK; Zeng J; Long Z; Lever AML; Kenyon JC
    Retrovirology; 2018 Mar; 15(1):25. PubMed ID: 29540207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of lentiviral vectors for transducing cells from the central nervous system.
    Li M; Husic N; Lin Y; Snider BJ
    J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.
    Wu X; Conway JA; Kim J; Kappes JC
    J Virol; 1994 Oct; 68(10):6161-9. PubMed ID: 8083957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production.
    Ramalingam D; Duclair S; Datta SA; Ellington A; Rein A; Prasad VR
    J Virol; 2011 Jan; 85(1):305-14. PubMed ID: 20980522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual mechanisms of translation initiation of the full-length HIV-1 mRNA contribute to gag synthesis.
    Monette A; Valiente-Echeverría F; Rivero M; Cohen ÉA; Lopez-Lastra M; Mouland AJ
    PLoS One; 2013; 8(7):e68108. PubMed ID: 23861855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.